The controversy about the potential for legalization has constantly been characterized by two positions: Some doctors and wellbeing industry experts warn towards trivializing cannabis. Neurologist Euphrosyne Gouzoulis-Mayfrank, incoming president from the German Modern society for Psychiatry, Psychotherapy and Psychosomatics (DGPPN), has report